Business Wire

EUROSCRIPT

Del
Life sciences content management software vendor INFOTEHNA joins euroscript

euroscript International S.A. (euroscript) has closed the acquisition of the Slovenia-based life sciences regulatory & compliance content management software vendor, INFOTEHNA Group LLC (INFOTEHNA). The majority of the shares has been acquired from the founder, with the management keeping its vested interests within the company. INFOTEHNA is a leader in the development and delivery of regulatory compliance solutions for the life sciences industry. Their broad customer base consists of some of the most prestigious leaders within the industry.

euroscript successfully develops solutions focusing on content-centric customer processes across several industries. The company not only provides industry specific business process services such as language, content-authoring and publishing services, but also supplies the applications supporting those processes. With this acquisition, euroscript makes another move to pursue its market development strategy, strengthening its life sciences segment by incorporating INFOTEHNA’s myPharmaExpert™ solution suite into their list of services. INFOTEHNA’s cutting-edge products further broaden euroscript’s portfolio with the addition of holistic compliance solutions for managing regulatory information, documents and processes.

The software solutions provided by INFOTEHNA boost euroscript’s ability to help customers in the regulated segment better manage the content by improving the overall product lifecycle management efforts, reducing time to market and introducing sustainable compliance.

Mark Evenepoel, CEO of the euroscript Group, explains: “We are impressed by the accomplishments of INFOTEHNA, its unique product architecture and vision. INFOTEHNA’s solutions for the life sciences industry are complementary to the services we currently offer in the regulated segments. The combination of euroscript and INFOTEHNA creates an unprecedented capability to provide customers worldwide with content management services, applications as well as ICT and life sciences consulting services, which are tailored to the needs of the industry segment – all from a single provider. We are pleased to welcome INFOTEHNA into the euroscript family and are excited about reinforcing our strategy in the life sciences segment by nominating Elvis Paćelat, INFOTEHNA’s CEO, as euroscript’s Vice President of Life Sciences.”

The integration of INFOTEHNA into the euroscript Group corresponds to the growing customer and market demand for the increased distribution and deployment capacity of myPharmaExpert™ suite on a worldwide basis, whilst the strategy and size of euroscript reinforces the impact and security of investment made by customers.
INFOTEHNA is delighted to join forces with euroscript to deliver content management products and services to the life sciences segment,” continues Elvis Paćelat. “This will enable INFOTEHNA to leverage a broader global presence by tackling our customers’ globalization challenges. euroscript’s implementation resources and global footprint provide the means for us to outgrow our competition.”

With the INFOTEHNA acquisition, euroscript employs a total of 1,550 people across 4 continents, with a pool of more than 300 experts focusing on designing, developing, implementing and maintaining ECM solutions, helping the group successfully address the challenges within Global Content Management, Marketing & Digital Experience Management, After Sales and Product Information Management, Plant Engineering Information Management, Official Publications, Research & Development, Regulatory Affairs & Information Management, Quality Assurance & Control, and Pharmacovigilance.

*****

About euroscript

euroscript is a leading provider in global content lifecycle management solutions. euroscript divisions deliver comprehensive solutions that help customers design, build and run content management operations of all sizes. Thanks to its employees’ expertise in the fields of consultancy, system integration, language services as well as content and document management, euroscript is able to help businesses worldwide to manage content more efficiently.

With a market presence in over 19 countries, euroscript serves customers in a variety of business sectors, including the public sector, aerospace, defense and transport, manufacturing, life sciences, financial services as well as energy and the environment.

Website: www.euroscript.com

About INFOTEHNA

INFOTEHNA is a worldwide leader in the development and delivery of the most advanced enterprise-regulated content and process management, as well as regulatory compliance solutions for life sciences industries.
INFOTEHNA’s advanced compliance solutions are developed by life sciences experts. Being the only vendor on the market offering the overall spectrum of compliance management functionality, INFOTEHNA's holistic product enables their clients to reduce the time to market for new products, improve overall Product Life Cycle Management and introduce sustainable compliance. Their solution suite offers extensive out of the box functionalities, and is also easily configurable, as well as capable of supporting singular compliance-relevant processes, or complete enterprise compliance management.
INFOTEHNA’s solutions are ready to be validated and deployed without expensive customization and offer the best total cost of ownership.

Website: www.infotehna.com

Contact:

Press Contacts
At euroscript
Anikó Füredi, + 351 21 421 63 50
E-mail: aniko.furedi@euroscript.com
or
At INFOTEHNA
Sonja Vlašič, Tel.: + 386 7 3930600
E-mail: sonja.vlasic@infotehna.com

Link:

ClickThru

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

AB InBev Reports First Quarter 2025 Results8.5.2025 07:03:00 CEST | Press release

Solid start to the year with EBITDA growth at the top-end of our outlook, continued margin expansion and high-single digit Underlying EPS growth Anheuser-Busch InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD): This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250507671244/en/ AB InBev Strategic Priorities Regulated information1 “Beer is a passion point for consumers. The strength of the beer category and the continued momentum of our megabrands delivered another quarter of profitable growth. EBITDA increased at the top-end of our outlook and the ongoing optimization of our business drove Underlying EPS growth of 7.1%. The consistent execution of our strategy by our teams and partners drove a solid start to the year and reinforces our confidence in delivering on our outlook for 2025.” – Michel Doukeris, CEO, AB InBev Revenue +1.5% Revenue increased by 1.5% with revenue per hl growth of 3.7%. Reported revenue decreased by 6.3%

Rimini Street and ServiceNow Partner with Apsen Farmacêutica to Deliver a Next-Generation Vision of Enterprise-Wide Workflow Automation7.5.2025 18:55:00 CEST | Press release

Pharmaceutical manufacturer layers ServiceNow over its existing SAP ECC 6 ERP platform, enables intelligent workflow and automation for immediate business impact and avoids low ROI spend on expensive, risky vendor-mandated migration to SAP S/4HANA Knowledge 2025 —Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, management and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today at ServiceNow’s annual customer and partner event, Knowledge 2025, announced that Apsen Farmacêutica, a Brazilian pharmaceutical manufacturer, has partnered with Rimini Street and ServiceNow to implement a next-generation vision of enterprise-wide workflow automation. This new vision will enable autonomy across the company to help respond faster to market changes, reduce information silos and improve operational efficiency. This press release features multimedia. View the full release here: https://www.busine

Results from the VirTus Respiratory Research Ltd Human Rhinovirus Challenge Model Used to Advance Altesa BioSciences’ Lead Medicine into Advanced Clinical Trials7.5.2025 18:07:00 CEST | Press release

Study conducted by VirTus Respiratory Research demonstrated that vapendavir has potent antiviral activity and improves symptoms in participants with COPD infected with rhinovirus VirTus Respiratory Research Ltd, a leading respiratory-focused contract research organisation (CRO), today announced that results from their human rhinovirus challenge model in patients with chronic obstructive pulmonary disease (COPD) provided Altesa BioSciences with compelling evidence to advance their lead drug candidate, vapendavir, into large scale, late-stage clinical trials. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250507489716/en/ Professor Sebastian Johnston https://www.prnewswire.com/news-releases/altesa-biosciences-details-positive-topline-vapendavir-results-from-phase-2-placebo-controlled-rhinovirus-challenge-study-in-copd-patients-302448650.html Rhinovirus infection is the cause of at least half of the acute respiratory deteriorat

FlightSafety International Announces Major Expansion at Farnborough Airport7.5.2025 17:56:00 CEST | Press release

FlightSafety International (FSI), a global leader in aviation training, is pleased to announce the expansion of its facilities at Farnborough Airport, the home of British aviation and Europe’s leading airport for premium air travel connectivity, highlighting its commitment to enhancing aviation safety and training excellence in Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250506583636/en/ Rendering: arriving at FlightSafety International The new FSI centre is expected to open in the second quarter of 2027. Lease terms have been finalised and the planning application was submitted in January. Construction is scheduled to start in late 2025 and finish by early 2027. FSI has operated a training centre at Farnborough Airport since 2004. The new facilities will boost training capacity by 40-50%, enabling more aviation professionals access to FSI's world-class training programmes. The current facility is 4,680 square met

Verimatrix Positioned as a Leader and Ace Performer in the 2025 SPARK MatrixTM for In-App Protection by QKS Group7.5.2025 17:45:00 CEST | Press release

The QKS Group SPARK Matrix™ provides competitive analysis and ranking of the leading In-App Protection vendors.Verimatrix is recognized for its comprehensive in-app protection capabilities, earning strong ratings across both Technology Excellence and Customer Impact in the latest SPARK Matrix™.Verimatrix has also been named an Ace Performer – a recognition given to vendors that demonstrate revenue growth potential, partnership strategy, and customer acquisition – all evaluated over the last one-year period or since the previous SPARK Matrix™ assessment. Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250507970501/en/ Verimatrix positioned as a Leader in the 2025 SPARK Matrix™ for In-App Protection by QKS Group. Verimatrix has been recognized for its comprehensive in-app protection capabilities, earning strong ratings across both Technology Excellence and Customer Impact in the latest SPARK Matrix™. The compan

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye